RxDoctor Payments Data

Michael Emerson, MD

Ophthalmology · Minneapolis, MNNPI 1649222902

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 15th percentile of 330 ophthalmology providers in Minnesota.

See all ophthalmology providers in Minnesota

Medicare billing

Part B allowed, 2024
$2,752,630
Medicare patients
969
Services billed
14,393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate207$11,460
Ketorolac Tromethamine85$2,116
Eplerenone27$1,790
Atropine Sulfate17$460
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat21$262
ValacyclovirValacyclovir Hcl11$109

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →